NRX-252262
CAS No. 2438637-61-5
NRX-252262( —— )
Catalog No. M24123 CAS No. 2438637-61-5
NRX-252262 is a potent enhancer of the interaction between β-Catenin, and its cognate E3 ligase, SCFβ-TrCP, induces mutant β-catenin degradation(EC50:3.8 nM)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 258 | In Stock |
|
10MG | 410 | In Stock |
|
25MG | 678 | In Stock |
|
50MG | 954 | In Stock |
|
100MG | 1287 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNRX-252262
-
NoteResearch use only, not for human use.
-
Brief DescriptionNRX-252262 is a potent enhancer of the interaction between β-Catenin, and its cognate E3 ligase, SCFβ-TrCP, induces mutant β-catenin degradation(EC50:3.8 nM)
-
DescriptionNRX-252262 is a potent enhancer of the interaction between β-Catenin, and its cognate E3 ligase, SCFβ-TrCP, induces mutant β-catenin degradation(EC50:3.8 nM).
-
In VitroNRX-252262 (35?μM) causes S33E/S37A mutant β-catenin degradation in cells.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorSCF(β-TrCP)-E3 ligase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2438637-61-5
-
Formula Weight545.36
-
Molecular FormulaC23H17Cl2F3N2O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:8 mg/mL?(14.67 mM;?Need ultrasonic)
-
SMILESO=C1C(C(N2CC3=C(C=C(OC)C(OC)=C3)C2)=O)=C(SC4=C(Cl)C=CC=C4Cl)C=C(C(F)(F)F)N1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kyle R. Simonetta, et al. Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction. Nature Communications. 2019 March.
molnova catalog
related products
-
TPI-1
TPI-1 is a SHP-1 inhibitor.
-
2-Methylbenzene-1-su...
Used for saccharin, pharmaceutical intermediates, etc.
-
HS-1793
HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model